Medication info
Altriton Plus Tablets

Altriton Plus Tablets

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Yu Young Pharmaceutical Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets (4 tablets/PTP x 1)
Approval status
Active

MFDS item code 201604675 · Approved 2016.07.28 · Insurance code 648203930

Summary

Main use
Treatment and prevention of postmenopausal osteoporosis; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 1 tablet orally once weekly Older adults: No dose adjustment is necessary in older adults (60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after food or beverages. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides one week's supply of vitamin D at a daily dose of 800 IU. If a patient forgets to take a dose on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
Safety and efficacy have not been established in children and growing adolescents.

Ingredients

Manufacturer
Yu Young Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of postmenopausal osteoporosis; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis, which can occur in both postmenopausal women and men.

How to take

Adult dose

Adults: Administer 1 tablet orally once weekly Older adults: No dose adjustment is necessary in older adults (60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after food or beverages. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides one week's supply of vitamin D at a daily dose of 800 IU. If a patient forgets to take a dose on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Safety and efficacy have not been established in children and growing adolescents.

Precautions

This medication may irritate the stomach and esophagus, which could lead to problems such as esophagitis or ulcers. If there is pain in the throat or chest or difficulty swallowing after taking this medication, discontinue use immediately and consult a doctor. Take the medication while sitting or standing with a sufficient amount of water, and do not lie down for at least 30 minutes after taking it. This medication should not be used by patients with certain esophageal diseases or severe renal impairment. Additionally, patients with genetic issues such as lactose intolerance should avoid taking it. It is important to ensure an adequate intake of calcium and vitamin D while taking this medication, and other causes of osteoporosis should also be considered. Since rare side effects such as osteonecrosis of the jaw may occur, attention should be paid to oral hygiene, and dental treatment should be consulted with a doctor. Moreover, if pain occurs in the back, joints, or muscles during medication, it should be reported immediately. It is advisable not to take this medication concurrently with other drugs or foods that contain calcium, magnesium, or iron, as this medication is not significantly metabolized in the body and is primarily excreted through the kidneys. If pregnant or breastfeeding, it is advisable to avoid this medication or consult a doctor thoroughly. Safety for children has not been established, and elderly patients can use it without special precautions. In case of overdose, monitoring for symptoms of hypocalcemia, as blood calcium levels may drop, is critical, and treatment such as calcium supplements or gastric lavage may be necessary. This medication should be stored out of the reach of children and should not be transferred to other containers.

Side effects

Hemorrhage, esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, perforation, dysphagia, odynophagia, pain behind the sternum, heartburn, infection, low back pain, pain, abdominal pain, throat pain, weakness, chest pain, neoplasm, hernia, hypertension, cardiovascular disease, angina, nausea, diarrhea, bloating, gastritis, gastrointestinal disease, rectal disease, dental disease, petechiae, anemia, joint pain, joint abnormalities, myalgia, bone pain, bone abnormalities, leg cramps, bursitis, tendon abnormalities, depression, dizziness, insomnia, anxiety, neuralgia, vertigo, hypertonia, sensory abnormalities, pharyngitis, rhinitis, dyspnea, pneumonia, rash, itching, skin cancer, cataracts, conjunctivitis, otitis media, urinary tract infection, cystitis, duodenitis, glossitis, hypocalcemia, hypophosphatemia, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, blisters, jawbone necrosis, liver dysfunction, jaundice, osteonecrosis of the external auditory canal, dyspepsia, loss of appetite, myalgia, weakness, heartburn, epigastric pain, chest discomfort, palpitations, increased sweating, facial flushing, burning sensation, kidney stones, belching, hematuria, fever, facial edema, hair loss, altered sense of smell, injury due to accident, epidemic cold syndrome, headache, overdose, allergic reaction, tumor, syncope, vasodilation, constipation, nausea, gastroenteritis, colitis, vomiting, thirst, peripheral edema, traumatic fracture, myalgia, arthritis, headache, dizziness, syncope, vasodilation, bronchitis, sinusitis, increased cough, influenza, nasopharyngitis, upper respiratory tract infection, fever, falling, neck pain, hypercholesterolemia, low back pain, joint pain, osteoarthritis, limb pain, muscle rigidity, myalgia, neck pain, weakness, chest pain, fever, headache, dizziness, depression, hypertension, cough, depression, hypercalcemia, hypercalciuria, loss of appetite, nausea, vomiting, polyuria, weakness, somnolence

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the effectiveness and safety of the medication.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets (4 tablets/PTP x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.